Industry Watch [to 4 February 2017]

Industry Watch [to 4 February 2017]
:: Milestone: 250 Million Pneumococcal Conjugate Vaccine Doses Delivered in Gavi Countries
Pfizer | 24 January 2017
We have delivered 250M doses of pneumococcal conjugate vaccine – protecting more than 20 million babies in Gavi countries. Using new technology, education, and sustainable investments, we are helping to support Gavi’s goal of immunizing an additional 300 million of the world’s poorest children against life-threatening diseases by 2020.

:: Sanofi Pasteur Announces the Availability of Quadracel DTaP-IPV Vaccine for Children 4 Through 6 Years of Age in the U.S.
SWIFTWATER, Pa., Jan. 31, 2017 /PRNewswire/ — Sanofi Pasteur, the vaccines division of Sanofi announced today the availability of Quadracel™ (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus; DTaP-IPV) vaccine in the United States. Quadracel is approved by the U.S. Food and Drug Administration (FDA) for active immunization against diphtheria, tetanus, pertussis and poliomyelitis in children 4 through 6 years of age…